These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7734937)

  • 21. Selective photo-cross-linking of 2'-O-psoralen-conjugated oligonucleotide with RNAs having point mutations.
    Higuchi M; Yamayoshi A; Yamaguchi T; Iwase R; Yamaoka T; Kobori A; Murakami A
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):277-90. PubMed ID: 17454737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleoside methylphosphonates as antisense reagents.
    Miller PS
    Biotechnology (N Y); 1991 Apr; 9(4):358-62. PubMed ID: 1367008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photoaffinity behavior of a conjugate of oligonucleoside methylphosphonate, rhodamine, and psoralen in the presence of complementary oligonucleotides.
    Thaden J; Miller PS
    Bioconjug Chem; 1993; 4(5):386-94. PubMed ID: 7506058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses.
    Masters PS; Banerjee AK
    Virology; 1987 Apr; 157(2):298-306. PubMed ID: 3029973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates.
    Delong RK; Miller PS
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):273-80. PubMed ID: 9012863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses of alternating oligo-2'-O-methylribonucleoside methylphosphonates and their interactions with HIV TAR RNA.
    Hamma T; Miller PS
    Biochemistry; 1999 Nov; 38(46):15333-42. PubMed ID: 10563819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular distribution of microinjected antisense oligonucleotides.
    Leonetti JP; Mechti N; Degols G; Gagnor C; Lebleu B
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2702-6. PubMed ID: 1849273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA.
    Jayaraman K; McParland K; Miller P; Ts'o PO
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1537-41. PubMed ID: 6165012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycistronic vesicular stomatitis virus RNA transcripts.
    Herman RC; Schubert M; Keene JD; Lazzarini RA
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4662-5. PubMed ID: 6254036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription.
    Hinzman EE; Barr JN; Wertz GW
    J Virol; 2002 Aug; 76(15):7632-41. PubMed ID: 12097577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.
    Blondel D; Harmison GG; Schubert M
    J Virol; 1990 Apr; 64(4):1716-25. PubMed ID: 2157054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing Tat peptide-TAR RNA interactions by psoralen photo-cross-linking.
    Wang Z; Shah K; Rana TM
    Biochemistry; 2001 May; 40(21):6458-64. PubMed ID: 11371209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.
    Leonetti JP; Machy P; Degols G; Lebleu B; Leserman L
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2448-51. PubMed ID: 2157200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages.
    Miller PS; Cassidy RA; Hamma T; Kondo NS
    Pharmacol Ther; 2000 Mar; 85(3):159-63. PubMed ID: 10739870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5' ends.
    Wang LX; Yang DC; Lu YY; Takagi Y; Taira K; Li T; Zhang LH
    Drug Des Discov; 1995 Nov; 13(2):109-21. PubMed ID: 8872455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete sequences of the ribosome recognition sites in vesicular stomatitis virus mRNAs: recognition by the 40S and 80S complexes.
    Rose JK
    Cell; 1978 Jun; 14(2):345-53. PubMed ID: 208778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the infections of permissive and nonpermissive cells by host range mutants of vesicular stomatitis virus defective in RNA methylation.
    Horikami SM; De Ferra F; Moyer SA
    Virology; 1984 Oct; 138(1):1-15. PubMed ID: 6093352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.
    Leonetti JP; Degols G; Lebleu B
    Bioconjug Chem; 1990; 1(2):149-53. PubMed ID: 1965625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative contribution of photo-addition, helper oligonucleotide and RNase H to the antisense effect of psoralen-oligonucleotide conjugates, on in vitro translation of Leishmania mRNAs.
    Pascolo E; Hudrisier D; Sproat B; Nguyen TT; Toulmé JJ
    Biochim Biophys Acta; 1994 Sep; 1219(1):98-106. PubMed ID: 8086483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of psoralen-derivatized oligodeoxyribonucleoside methylphosphonates with synthetic DNA containing a promoter for T7 RNA polymerase.
    Lee BL; Blake KR; Miller PS
    Nucleic Acids Res; 1988 Nov; 16(22):10681-97. PubMed ID: 3060847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.